Benign prostatic hyperplasia: does prostate size matter?, Rev Urol, vol.5, pp.12-19, 2003. ,
MOLECULAR AND CELLULAR PATHOGENESIS OF BENIGN PROSTATIC HYPERPLASIA, The Journal of Urology, vol.172, issue.5, pp.1784-91, 2004. ,
DOI : 10.1097/01.ju.0000133655.71782.14
Expression of Transforming Growth Factor-??1 and Transforming Growth Factor-?? Receptors in Hepatocellular Carcinoma and Dysplastic Nodules, Modern Pathology, vol.16, issue.1, pp.86-96, 2003. ,
DOI : 10.1097/01.MP.0000047308.03300.9C
BPH Gene Expression Profile Associated to Prostate Gland Volume, Diagnostic Molecular Pathology, vol.17, issue.4, pp.207-220, 2008. ,
DOI : 10.1097/PDM.0b013e31816f6352
URL : https://hal.archives-ouvertes.fr/inserm-00349851
Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis, The Prostate, vol.57, issue.16, pp.1774-80, 2009. ,
DOI : 10.1002/pros.21027
URL : https://hal.archives-ouvertes.fr/inserm-00440934
Genetic Profiling of Gleason Grade 4/5 Prostate Cancer: Which is the Best Prostatic Control Tissue?, The Journal of Urology, vol.170, issue.6, pp.2263-68, 2003. ,
DOI : 10.1097/01.ju.0000096414.25583.0d
Increased expression of genes for basic fibroblast growth factor and transforming growth factor type ??2 in human benign prostatic hyperplasia, The Prostate, vol.138, issue.1, pp.71-80, 1990. ,
DOI : 10.1002/pros.2990160108
Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological Malignancy, The Journal of Urology, vol.153, issue.4, pp.1085-96, 1995. ,
DOI : 10.1016/S0022-5347(01)67516-5
Transforming Growth Factor ?? and its Receptor Types I and II. Comparison in Human Normal Prostate, Benign Prostatic Hyperplasia, and Prostatic Carcinoma, Growth Factors, vol.71, issue.2, pp.101-111, 1998. ,
DOI : 10.1016/0092-8674(92)90627-O
Expression of Transforming Growth Factor-?? in the Rat Ventral Prostate during Castration-Induced Programmed Cell Death, Molecular Endocrinology, vol.3, issue.10, pp.1515-1537, 1989. ,
DOI : 10.1210/mend-3-10-1515
Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression, Mol Endocrinol, vol.10, pp.107-122, 1996. ,
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty, The FASEB Journal, vol.19, pp.243-288, 2005. ,
DOI : 10.1096/fj.04-2415fje
Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta, Front Biosci, vol.8, pp.740-789, 2003. ,
Proliferation and differentiation of prostatic stromal cells, BJU International, vol.35, issue.Suppl 5, pp.386-93, 2001. ,
DOI : 10.1046/j.1464-410x.2001.00103.x
Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis, The Prostate, vol.1, issue.3, pp.189-200, 2002. ,
DOI : 10.1002/pros.10087
Molecular genetic aspects of prostate transition zone lesions, Urology, vol.62, issue.4, pp.607-620, 2003. ,
DOI : 10.1016/S0090-4295(03)00501-6
Peptide growth factors in the prostate as mediators of stromal epithelial interaction, BJU International, vol.77, issue.5, pp.627-660, 1996. ,
DOI : 10.1046/j.1464-410X.1996.09721.x
Profiling molecular targets of TGF-??1 in prostate fibroblast-to-myofibroblast transdifferentiation, Mechanisms of Ageing and Development, vol.126, issue.1, pp.59-68, 2005. ,
DOI : 10.1016/j.mad.2004.09.023
Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays, Proceedings of the National Academy of Sciences, vol.99, issue.11, pp.7598-7603, 2002. ,
DOI : 10.1073/pnas.112191399
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC124296
Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study, Prostate Cancer Prostatic Dis, issue.3, pp.8215-8223, 2005. ,
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract ,